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Autophagy is a highly conserved cellular process occurring during periods of stress to ensure a cell’s survival by recycling
cytosolic constituents and making products that can be used in energy generation and other essential processes. Three major
forms of autophagy exist according to the speciﬁc mechanism through which cytoplasmic material is transported to a lysosome.
Chaperone-mediated autophagy is a highly selective form of autophagy that delivers speciﬁc proteins for lysosomal degradation.
Microautophagy is a less selective form of autophagy that occurs through lysosomal membrane invaginations, forming tubes
and directly engulﬁng cytoplasm. Finally, macroautophagy involves formation of new membrane bilayers (autophagosomes) that
engulf cytosolic material and deliver it to lysosomes. This review provides new insights on the crosstalks between diﬀerent forms
of autophagy and the signiﬁcance of bilayer-forming phospholipid synthesis in autophagosomal membrane formation.
1.Introduction
Eukaryoticcellshaveevolvednumerouspathwaystoimprove
survivalinharshenvironments.Onesuchpathway,knownas
autophagy, specializes in the breakdown of cell components
through speciﬁc and nonspeciﬁc delivering to the lysosome.
The products of lysosomal degradation can then be used for
the biosynthesis of new proteins and organelles and as an
energy source [1]. To date, three forms of autophagy have
been identiﬁed and characterized. This review will discuss
key ﬁndings in autophagy research as well as provide new
insights on the role of membrane lipids in autophagosome
formation.
Three major forms of autophagy have been identiﬁed
in cells: chaperone-mediated autophagy (CMA), microau-
tophagy (MiA), and macroautophagy (MaA). CMA is a
selective protein delivering system which uses speciﬁc heat
shock protein complexes (HSPC) to deliver proteins to
the lysosome for degradation [2]. CMA is unique in
that it specializes in the sequestration and degradation of
a single-protein substrate, whereas both MiA and MaA
specialize in bulk sequestration and degradation of cytosolic
components. MiA is characterized by the engulfment of
cytoplasm (including proteins and organelles) by membrane
invagination of lysosome and/or endosome in mammals, or
vacuole in yeast [3]. Finally, MaA is distinguished by the
formation of a specialized double-membrane vesicle termed
the autophagosome, which forms around the material to be
digested (organelles/proteins). Once the autophagosome is
formed, it fuses with a lysosome forming an autolysosome
[4]. Though similar in their means of cargo degradation, the
three forms diﬀer in the manner that they use to deliver their
cargo to the lysosome.
To date, most autophagy research has been directed
towards MaA, resulting in large gaps in our understanding
of CMA and MiA processes. However this does not mean
that these processes are any less important than MaA, as
numerous studies have identiﬁed an association between
various diseases (Parkinson’s disease, Alzheimer’s disease,
type-II diabetes, obesity, cardiovascular disease, and cancer)
and generally unregulated or defective autophagy processes
[5–12]. And, as will be shown in this review, surmounting2 International Journal of Cell Biology
evidencesuggeststhatthereisconsiderablecrosstalkbetween
these three pathways.
2. Chaperone-MediatedAutophagy
CMA is a speciﬁc form of autophagy targeting only soluble
proteins for delivery to the lysosome. In order for a
protein to be degraded, its speciﬁc motif KFERQ is initially
recognized by a large heat shock protein complex (HSPC,
Figure 1). The HSPC is made from three heat shock proteins
(Hsc70, Hsp40, and Hsp90), Hsc70-interacting protein
(Hip), Hsc70-Hsp90-organizing protein (Hop), and Bcl2-
associated athanogene 1 protein (BAG-1) (Figures 1(a)–
1(c)). Within the complex, Hsc70 speciﬁcally recognizes
the KFERQ motif of the substrate protein. The interaction
between Hsc70 and the substrate protein is controlled by
ATP hydrolysis where the ADP-bound form of Hsc70 has the
greatestaﬃnityforthesubstrate[13].Theothercomponents
of the HSPC complex act as cochaperones regulating the
activity of Hsc70. The ADP bound form of Hsc70 then
targets the HSPC to the lysosomal membrane. Transport
of the protein substrate into the lumen of the lysosome
requires a transmembrane protein called the lysosome-
associated membrane protein 2A (LAMP2A), which acts as
a receptor for substrate proteins and has been proposed to be
a rate limiting step in the CMA pathway [13–15]( Figure 1).
LAMP2A is one of three splice variants of the LAMP2 gene.
It contains a large heavily glycosylated portion within the
lumen, a ∼20 amino acid transmembrane component, and
∼12 amino acid tail on the cytosolic side of the lysosome
[16]. The three splice variants contain a similar luminal and
transmembrane portion and diﬀer in their cytosolic tails.
The short cytoplasmic tail of LAMP2A contains four positive
amino acids (KRHH/KHHH) speciﬁcally required for the
translocation of the substrate protein into the lysosome
[17]. Once the substrate binds to the LAMP2A monomer,
a 700kDa LAMP2A complex forms, and it, as well as a
luminal chaperone (lys-Hsc70) aid in protein translocation
into the lumen of the lysosome, where it is degraded [14, 18].
Importantly, before the protein can be transported into the
lysosomal lumen, it must ﬁrst be unfolded at the lysosomal
surface (Figure 1(d)).
3. Chaperone-MediatedAutophagy Regulation
Generally speaking, CMA regulation is poorly understood,
but it is acknowledged that levels of LAMP2A are controlled
mainly through its assembly and disassembly within the
lysosome itself, and not through gene expression within
mammalian cells. During disassembly, LAMP2A is ﬁrst
truncated before entering the lumen where it is degraded.
During nutrient deprivation, degradation rates of LAMP2A
are reduced and remain so for a longer duration at the
lysosomal membrane, allowing CMA to occur at greater
rates [17]. Hsc70 has recently been shown to play a
major role in the disassembly of the LAMP2A complex,
whereas luminal Hsp90 stabilizes LAMP2A at the lysosome
membrane [18] and the lysosomes which contain a higher
amount of lys-Hsc70 seemingly have more active CMA
[19].
4. Microautophagy
In MiA, a direct invagination of a specialized vesicular mem-
brane takes in cytoplasm from the surrounding environment
(Figure 2). This invagination grows and forms a narrow
tube which elongates into the interior (Figure 2(a)). This
tube is referred to as the autophagic tube and is continuous
with the cytoplasm (Figure 2(b)). As the tube reaches the
interior of the vesicle, the proximal membrane ends form a
bulge, referred to as the autophagic body (Figure 2(c)). This
bulging end is thicker than the tube leading into the interior.
The walls of the bulging end of the autophagic tube then
fuse, pinching oﬀ into the inner portions of the lysosome
(Figure 2(d)). The cytosolic components trapped within the
body are degraded within the vacuole (lysosome) or the
vacuole will later fuse with a lysosome and the components
degraded [3].
Similar to CMA, the processes involved in the regulation
of MiA still need to be elucidated. However within yeast,
studies have shown that within the later stages of MiA the
pinching of the vesicle at the interior end of the autophagic
tubule is controlled through a vacuolar transporter cochap-
erone (VTC) complex, a protein which is localized at the
endoplasmic reticulum (ER) and on vacuolar membranes.
Although the autophagic tubule was produced, the pinching
oﬀ of the vesicle from the tube was impaired when VTC
complex formation was prevented [3]. It also appears that
calmodulin plays an important role during invagination of
the autophagic tubule. Although this interaction is calcium
independent, VTC has been identiﬁed as a direct target
of calmodulin, strengthening the role of VTC during MiA
[3, 20].
5. Nuclear or Piecemeal Microautophagy
Extensiveresearchinyeasthasidentiﬁedaformofautophagy
in which portions of the nucleus undergo degradation
through a MiA-like process. The outer nuclear membrane
interacts with the vacuole through a nucleus-vacuole junc-
tion mediated by the nucleus vacuole junction 1 protein
(Nvj1p) localized on the outer nuclear membrane and
vacuolar8protein(Vac8p)foundonthevacuolarmembrane
[21]( Figure 3). After the contact, the vesicle invaginates
inward pulling on the outer membrane of the nucleus
and the components into the autophagic body where they
are later released into the vacuole [22]( Figure 3). After
upregulationofpiecemealMiAwithrapamycin,anincreased
presence of the chaperone VTC was observed at the nuclear-
vacuole junction, suggesting a speciﬁc role of VTC in this
process [23]. Interestingly, the nuclear protein Nvj1p is also
responsible for the recruitment of Tsc13, a protein which
plays a role in the synthesis of very-long-chain fatty acids,
and Osh1, a protein responsible for nonvesicular lipid trans-
port. The recruitment of Tsc13 and Osh1 in MiA suggests
that additional lipids may be required for the formationInternational Journal of Cell Biology 3
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Figure 1: Chaperone-mediated autophagy. The KFERQ sequence of the substrate protein is protected by its three-dimensional structure,
preventing its interaction with the CMA heat shock protein complex (HSPC) (a). Unfolding or improper folding of the protein (b) allows
the HSPC to bind to the protein (c), targeting the protein to the lysosome for degradation (d). The CMA-speciﬁc protein is unravelled at the
lysosomal membrane by HSPC and transported into the lysosome via a channel formed from LAMP2A. Lysosomal Hsc70 (ly-Hsc70) pulls
the CMA speciﬁc protein into the lumen of the lysosome, where it is degraded.
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Figure 2: Microautophagy. A direct invagination of a vesicular membrane (lysosome and/or endosome) takes in cytoplasm from the
surrounding environment (a). This invagination continues and forms a narrow tube which elongates into the interior of the vacuole (b).
This tube is referred to as the autophagic tube and is continuous with the cytoplasm. Entire organelles or compounds within the taken up
cytoplasm are degraded within the lumen of the vacuole (if taken in via the lysosome) or fusion with a lysosome occurs, which results in the
breakdown of the captured cytosolic components. As the tube reaches the interior of the vacuole, the proximal ends form a bulge referred to
as the autophagic body (c). This bulging end is thicker than the tube leading into the vacuole. The walls of the bulging end of the autophagic
tube will then fuse, pinching oﬀ into the inner portions of the lysosome (d). The cytosolic components trapped within the vesicle are then
degraded within the vesicle (lysosome or vacuole) or the vesicle (endosome) will later fuse with a lysosome, where the components are then
degraded.
of the inner membranes forming within the vacuole [24].
Finally, similar to CMA, MiA and MaA also occur at similar
times during certain stimuli (nutrient deprivation) and the
proteins speciﬁc for MaA are actively involved in piecemeal
MiA. Autophagy-related proteins, Atg3, Atg7, Atg12, Atg16,
Atg1,andVPS(vacuolarproteinsorting)30,andmanyother
proteins which play key roles in MaA were shown to play
a c t i v er o l e si np i e c e m e a lM i A[ 25].
6. Endosomal Microautophagy
There has been a selective and nonselective form of endo-
somal MiA identiﬁed [26]. In the selective form (sim-
ilar to CMA, Figure 1) proteins containing the KFERQ
sequence were targeted for degradation after binding to
Hsc70. LAMP2A is not localized on the late endosomes
(LE), suggesting that Hsc70 is interacting with the LE4 International Journal of Cell Biology
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Figure 3: Piecemeal Microautophagy. In yeast, the vacuole and
nuclear membrane form a tight junction between proteins Vac8p
(Vacuole) and Nvj1p (Nuclear) (a). As the vacuole invaginates, the
nuclear membrane is pulled inward due to the interaction between
Vac8p and Nvj1p (b). This continues until an autophagic-like body
forms within the vacuole and pinches oﬀ from the membrane (c)
andisreleasedintothevacuolewhereitislaterdegraded(d).Vac8p:
Vacuolar 8 protein; Nvj1p: nucleus vacuole junction 1 protein.
membrane through a mechanism unlike CMA during the
delivery of speciﬁc proteins (KFERQ sequence) for degra-
dation. Interestingly, Hsc70 has a preference for interacting
with regions of membrane containing acidic phospho-
lipids (phosphatidylserine, phosphatidylinositol, and phos-
phatidylglycerol). When considering the composition of
cellular membranes, it is likely that phosphatidylserine (PS)
is largely responsible for the interaction between the LE and
Hsc70 due to its ability to play a role in protein localization
[27]. Additionally, the endosomal MiA relies on ESCRT
1 and 3 systems for the formation of the MiA vesicles.
When ESCRT functioning was disrupted, although a thin-
like vesicle (autophagic tubule) was formed within the LE,
pinching oﬀ of the vesicle did not occur [26].
7. Microautophagy Regulation
The target of rapamycin (TOR), the central regulator in cell
growth in yeast, and mammalian cells can exist in two forms,
TOR1andTOR2(mTOR1andmTOR2inmammaliancells).
Interestingly, it is TOR1 which, when active, decreases the
rate of protein synthesis, causing an arrest in the cell cycle
and mimicking the eﬀects seen during nutrient starvation,
and preventing macroautophagy from occurring. TOR is a
positive regulator of microautophagy due to its relationship
with the EGO complex, which is made up of EGO1, EGO2,
GTR1, and GTR2 [28, 29]. TOR1 and the EGO complex
colocalize with Vam6 at the vacuolar endosomal membrane
[30]. In fact it is now believed that the subunits GTR1 and
GTR2 of the EGO complex may play a vital role in regulating
the activity of TOR1 in yeast [30, 31]( Figure 4).
Interestingly the EGO complex is also located on the
vacuolar membrane in yeast and was shown to play a role in
monitoring the size of the vacuole during microautophagy.
Through continuous fusion of autophagosomal membranes
withthevacuole,thesizeofthevacuolecontinuestoincrease,
but as microautophagy levels increase, the internalization of
themembraneofthevacuoleoccurspreventingenlargement.
The vesicle then buds oﬀ into the lumen of the vacuole,
and the high lipid content of the vesicle is degraded. In
fact mutants of EGO1 and EGO2 developed larger vacuoles,
suggesting that the EGO complex is unable to induce
internalization of the membrane to prevent vacuolar growth
[32].
8. Macroautophagy
In MaA, a double-membrane structure termed an auto-
phagosome is formed (Figure 5). This specialized vesicle
delivers its engulfed material to a lysosome via membrane
fusion, forming an autolysosome. Once fusion with a
lysosome occurs, the components within the autolysosome
are degraded (Figure 5).
Three events must occur in order to form a fully
functionalautophagosomeinmammaliancells.Theﬁrststep
is the nucleation event, where recruitment of an early kinase
complex is believed to trigger the synthesis of the autophago-
somal isolation membrane (IM) [33, 34]( Figure 5). The
speciﬁc site of autophagosome formation is believed to
occur in a region of the endoplasmic reticulum (ER) called
the omegasome [35] .T h es e c o n ds t e po fa u t o p h a g o s o m e
formation is characterized by the expansion of the IM.
Finally, a fully functional autophagosome is formed through
membrane fusion of the IM.
During the nucleation event, recruitment of a large
serine/threonine complex consisting of autophagy-related
protein 13 (ATG13), focal adhesion kinase family interacting
protein (FIP200), Unc-51-like kinase 1 (ULK1), and ATG-
101 translocates to the ER region of the omegasome [33, 36]
(Figure 5). Translocation of this complex induces recruit-
ment of the large-class-III phosphoinositide 3 kinase (PI3K)
complex consisting of vacuolar protein sorting (VPS)-34,
VPS-15, BAX interacting protein-1, Beclin, and ATG-14 to
the omegasome [7, 33]. The large PI3K complex then phos-
phorylates phosphatidylinositol to phosphatidylinositol-3
phosphate (PI(3)P) and the PI(3)P bound proteins, WD-
repeat protein interacting with phosphoinositide-2 (WIPI2)
anddoubleFYVE-containingprotein1(DFCP1),translocate
to the same region [33, 37]. WIPI2 and DFCP1 then
promote the recruitment of the phospholipid carrier LC3-
II (microtubule-associated light chain 3) to the isolation
membrane. Since it is understood that the ATG5-ATG12-
ATG16L speciﬁes the site for LC3-I lipidation, it is possible
that WIPI2 and DFCP1 may be positively eﬀecting LC3-
II formation via an interaction with ATG5-ATG12-ATG16L
[38, 39]. The fully formed autophagosome then delivers
the cytosolic components to a lysosome via vesicle fusion,
forming an autolysosome (Figure 5). Lysosomal digestive
enzymes contained within the autolysosome degrade the
proteins and/or organelles, and degradation products are
recycled for use in energy generation or other processes.International Journal of Cell Biology 5
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9. Macroautophagy Regulation
The most important regulator of MaA is the mammalian
target of rapamycin (mTOR), a serine/threonine protein
kinase.Duringnutrientrichstates,mTORisactiveandphos-
phorylates ATG13, preventing its association with a large
activatingcomplex(ATG13-FIP200-ULK1-ATG101)vitalfor
the initiation of autophagosome formation (Figure 6). When
ATG13 is phosphorylated, it does not associate with FIP200,
Unc 51 like kinase 1 (ULK1), and ATG101, which prevents
autophagy from occurring. During periods of low-energy,
amino acids and/or growth factors, mTOR is inhibited
through phosphorylation of AMPK [32]. Since mTOR is
a negative regulator of autophagy, its inhibition allows
the formation of the large ATG13-FIP200-ULK1-ATG101
complex and it subsequently translocates to the ER to initiate
thenucleationoftheisolationmembrane(Figure 6)[25,35].
Translocation of the serine/threonine complex then induces
recruitment of the large-class-III PI3K complex and ATG-14
to the ER [36, 40].
10. CrosstalkbetweenMaA and CMA
In conditions of stress similar to which induce MaA, an
upregulation in CMA results, and both processes appear to
be vital to cell survival. For instance, studies in ﬁbroblasts
have shown that MaA activity rates peak within the ﬁrst
few hours of starvation. However, if the cell remains in
this state for longer than 6 hours, CMA activity levels rise
above those of MaA and reach maximal activity at about 20
hours [41]. Since MaA is a nonselective process, if its rates
were to remain high, it would eventually lead to cell death
due to the non-speciﬁc degradation of organelles and/or
proteins required for survival and proper functioning of the
cell. Through activation of CMA, the cell is able to target
only nonvital proteins, allowing it to survive and function
properly in a nutrient-deprived environment. Therefore it is
the consecutive pairing of these two processes that maintains
a cell’s viability under adverse conditions. Furthermore,
in situations that do not allow for CMA activity, such as
the presence of large protein complexes which obstruct6 International Journal of Cell Biology
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Figure 6: mTOR and AMPK regulation of macroautophagy. During nutrient rich conditions, mTOR remains active, phosphorylating
ATG13, preventing its ability to form the large activating complex for autophagy (ATG13-FIP200-ULK1-ATG101). During periods of
nutrient deprivation (amino acid deprivation, growth factor deprivation, and/or low-energy status), AMPK is activated and phosphorylates
mTOR, preventing its ability to phosphorylate ATG13. This allows ATG13 to form the large activating complex, leading to the induction of
autophagy. ATG: autophagy-related protein; P: phosphate; AMPK: adenosine monophosphate kinase; FIP200: focal adhesion kinase family-
interacting protein of 200kDa; ULK1: Unc-51-like kinase 1; mTOR: mammalian target of rapamycin.
CMA machinery, MaA is upregulated to eliminate protein
aggregates and ensure cell survival [41]. It is becoming
increasing clear that there is an important link between MaA
and CMA, as both pathways use similar machinery to carry
out their respective actions. Moreover both pathways are
upregulated by similar conditions including nutrient depri-
vation, oxidative stress, and/or improper protein folding in
the ER. The crosstalk between CMA and MaA was most
evident when MaA became upregulated in cells defective in
the CMA-speciﬁc protein LAMP2A. The exact manner in
which the cells compensated for decreased CMA activity is
not fully understood but an overlap in proteins involved
in both autophagy pathways was oﬀered as a plausible
mechanism.IntheabsenceofLAMP2Aactivity,theassembly
ofthelargeCMAcomplexbecamepreventedandcellshadan
increased availability of proteins required for CMA. If these
same proteins are also required for MaA, that would lead to
increase this process [42, 43].
11. Phospholipid Synthesis andthe Formation
of the Isolation Membrane
Despite the advances in autophagy research over the last
few decades, one area of research still remains poorly
understood. Due to the lack of lipid speciﬁc biomarkers
and adequate functional assays, scientiﬁc understanding of
the origin and source of the autophagosomal membranes
remains incomplete. Recent evidence of the contribution
of phospholipids to various processes including membrane
f u s i o na n dc e l ls u r v i v a lp a t h w a y sh o w e v e rp o i n t st oa
functional capacity of phospholipids outside of their normal
structural role [42–45].
Phosphatidylcholine (PC), phosphatidylethanolamine
(PE), and phosphatidylserine (PS) are essential bilayer form-
ing lipids in all cells. PC is predominately found in the outer
leaﬂetofthecellmembraneandPEandPSmakeuptheinner
leaﬂet phospholipids [46, 47] .P Ea n dP Sh a v eb e e ns h o w n
to redistribute within the membrane under certain stress
conditions [44, 48] where higher concentrations of PE and
PS were found in the outer leaﬂet of the plasma membrane
preceding cell-to-cell fusion of myoblasts to form myotubes
[45]. Similarly, during cytokinesis, PE was found on the
outer leaﬂet of the plasma membrane and at the cleavage
furrow during late telophase [49]. These and other ﬁndings
demonstrate a necessary capacity of the inner membrane
phospholipids PE and PS in membrane fusion. Finally,
several studies have identiﬁed a distinct function of PS in cell
survival whereby localization of PS to the outer membrane
leaﬂet of cells under stress or apoptotic conditions acts as a
recognition signal for phagocytic binding [48, 50, 51].
Some of the leading hypotheses on the source of the
autophagosomal membrane include the ER, the Golgi appa-
ratus, the mitochondria, and the plasma membrane [52–55].
Increasing evidence however suggests that the ER plays a
signiﬁcant function in autophagosome formation by provid-
ing phospholipids for autophagosome membrane initiation
and expansion. Two models propose a role for the ER in
autophagosome formation. The ﬁrst model suggests that the
autophagosome originates from a ribosome-free region of
the rough ER [56, 57]. However, a lack of certain ER markers
(P450 and PDI) on the IM suggests that autophagosomes
are not derived from the ER via direct maturation [35, 58–
60]. In fact, IMs and mature autophagosomes were reported
to appear as nascent membranes, whereby any proteins
present on the membrane would have to be stripped for the
maturation model to hold true [61–63]. However, protein
removal from membranes is an energetically expensive
process and the synthesis of new membranes from localized
lipid sources is a more plausible explanation [64], which
altogether ﬁts into the second model proposing that the
ER plays a fundamental role in autophagosome formation
through providing newly synthesized lipids, notably the
phospholipids PE, PC, and PS as described here in after.
The biochemical pathways for phospholipid synthesis
are described in Figure 7. The Kennedy pathway accountsInternational Journal of Cell Biology 7
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Figure 7: Phospholipid biosynthetic pathways. PE is made by
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methyltransferase: PEMT; phosphatidylserine synthase 1: PSS1;
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for bulk synthesis of PE and PC through two independent
branches of the pathway: CDP-ethanolamine and CDP-
choline, respectively. In the CDP-ethanolamine pathway,
ethanolamine (Etn) is phosphorylated by ethanolamine
kinase (EK) to form phosphoethanolamine (Etn-P), which
is then converted by CTP: phosphoethanolamine cytidyl-
transferase (Pcyt2/ET) into CDP-ethanolamine (CDP-Etn).
Finally, PE is formed from CDP-ethanolamine and dia-
cylglycerol (DAG) by CDP-ethanolamine: 1,2-diacylglycerol
ethanolaminephosphotransferase (CEPT) [65]. Alterna-
tively, PE can also be synthesized by the decarboxylation of
PS through the action of phosphatidylserine decarboxylase
(PSD) within the mitochondria [66, 67]( Figure 7 left).
Analogous to PE synthesis via the CDP-ethanolamine
pathway, PC production via the CDP-choline pathway
begins with the phosphorylation of choline via choline
kinase (CK) to form phosphocholine (P-choline). CDP-
choline is produced from phosphocholine via phospho-
choline cytidyltransferase (Pcyt1/CT) and ﬁnally condensed
withDAGtoformPC(Figure 7right).PCcanbesynthesized
by two additional pathways: PE synthesized through the
CDP-ethanolamine pathway can be converted to PC via
the enzyme phosphatidylethanolamine N-methyltransferase
(PEMT), or through the decarboxylation of PS to form PE,
whichcanthenbemethylatedtoformPC[68–70](Figure 7).
Unlike PE and PC, which are primarily synthesized de novo,
PS is synthesized largely via an exchange reaction with
preexisting PE by phosphatidylserine synthase 1 (PSS1) or
with preexisting PC by phosphatidylserine synthase 2 (PSS2)
in mitochondria-associated regions of the ER [71]. It should
be noted that while the bulk of the Kennedy pathway takes
placeinthecytoplasm,theﬁnalstepsofPEandPCformation
occur in the ER [71–77]. Similarly, the ﬁnal synthesis of
phosphatidylinositol (PI), a phospholipid required in the
early stages of autophagosome formation, occurs at the ER
through the action of phosphatidylinositol synthase [77, 78].
Though this enzyme is located in other regions of the cell,
such as the plasma membrane or Golgi, it is accepted that
the bulk of PI synthesis occurs at the ER [79]. Thus the ER
is involved in the synthesis of all types of phospholipids (PE
PC, PS, and PI) necessary for autophagosome biogenesis.
Recent studies examining the role of the Kennedy
pathway in autophagy showed that when autophagy was
induced by starvation in mouse hepatoma cells, activity
of the rate limiting enzyme in the CDP-ethanolamine
pathway, ET, increased. Furthermore, during autophagy, an
increased synthesis of all membrane-forming phospholipids
was seen at the level of the ER and PE produced in
this pathway became incorporated into LC3 under these
same conditions [64]. The ER model for autophagosome
phospholipids is made even more convincing by studies
conducted by J. Vance, which showed that newly synthesized
phospholipids are favoured over preexisting phospholipid
stores for organelle membrane production in rat hepatocytes
[80]. These data were conﬁrmed more recently by H¨ orl et al.
who showed that lipid droplet formation requires de novo
synthesis of PC in 3T3-L1 adipocytes [81].
Further evidence of the role of the ER in autophagosome
formation is provided by the discovery that under starvation
conditions, DFCP1 (double FYVE-containing protein 1) a
PI(3)P-binding protein, translocates to the ER to form an
omegasome [33]. Generation of an omegasome by DFCP1
is suggested to be necessary for the recruitment of the
ATG5-ATG12-ATG16L complex, and subsequently LC3 to
the omegasome [39, 82]. Moreover, more recent studies by
Yla-Antilla et al. and Hayashi-Nishino et al. demonstrated
that the ER associates with the IM, forming what Hayashi-
Nishino et al. have deemed an ER-IM complex in mam-
malian cells [35, 53, 82]. In fact, electron-tomography data
of ER-IM complexes have revealed a physical connection
between the ER and the IM, whereby the inner and outer
surfaces of the IMs were shown to be directly connected
with the ER [83]. Interestingly, once the IMs matured into
autophagosomes, the connection between the ER and the
IMs was lost, further supporting the position that the ER is
involved in the process of IM formation and elongation [35].
12. Conclusion
Considering the work on the forms of autophagy has
increased, there is still a large gap in understanding how
these processes are regulated. It now appears that the
autophagosomal membrane is synthesized de novo during
upregulation of MaA, although it is unknown whether
synthesis of new membrane is required during MiA or
CMA. Studies which prevent the proper functioning of
phospholipid synthesizing enzymes will determine whether8 International Journal of Cell Biology
de novo synthesis of membrane is required for these forms
of autophagy. Additionally, what is becoming increasingly
clear is how MaA, MiA, and CMA are linked and share
the same and/or similar proteins. Increased investigation of
the crosstalk between these forms of autophagy will help to
understandthespeciﬁcrolesthesesystemsplay(togetherand
separately) in the removal of cellular material.
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